Eli Lilly in India: Rethinking the Joint Venture Strategy - podcast episode cover

Eli Lilly in India: Rethinking the Joint Venture Strategy

Dec 03, 202029 minEp. 7
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Professor Charles Dhanaraj explains how he modified a heavily tested and adjusted teaching plan once again, this time for the virtual classroom. How do we connect synchronous and asynchronous approaches, design breakout groups, and wrap-up a case method class successfully in what is a new environment for many instructors? Dhanaraj is Evelyn & Jay G. Piccinati Endowed Chair in Teaching Excellence, professor and chair of the Department of Management at the Daniels College of Business, University of Denver.   Eli Lilly in India: Rethinking the Joint Venture Strategy Charles Dhanaraj, Paul W. Beamish, Nikhil Celly Eli Lilly in India documents the evolution of an international joint venture (IJV) over a 10-year period (1991 to 2001) between • Eli Lilly, a leading U.S. pharmaceutical company and • Ranbaxy, the Indian partner that marked Lilly’s entry into an emerging market, India. The case highlights three distinct phases of the evolution of the IJV and raises relevant management issues at different phases of the IJV's growth. Review the case here

For the best experience, listen in Metacast app for iOS or Android